Source abstract
Abstract
Nanoparticle drug delivery systems have significant potential to transform precision medicine due to their ability to encapsulate a wide range of cargo, improve systemic circulation time, and enhance targeted delivery. These delivery properties can be further modified by altering the surface chemistry of the nanoparticle carrier. However, a gap remains in our understanding of the cellular mechanisms underlying nanoparticle uptake, in addition to the subcellular trafficking kinetics. A comprehensive understanding of nanoparticle-cell interactions considering both the nanocarrier and the drug cargo has been challenging, in part due to technological limitations. Here, we present a robust imaging workflow to study long-term dynamics of nanoparticle delivery in live cells. We show that integration of holography and tomography enhances the study of live cells in a label-free environment and can be combined with intermittent fluorescence microscopy to assess nanoparticle uptake and delivery kinetics for up to 30 hours. We also describe a method to quantitatively characterize uptake of a library of fluorescently tagged lipid- and polymer-based nanoformulations without introducing cell or organelle markers. This application of dynamic fluorescent holotomography as a novel method to investigate nanoparticle uptake and cargo delivery highlights the expanding utility of multimodal, label-free, live imaging techniques.
Source: openalex_inverted_index · Quality: candidate unverified ·
Source record ↗Affiliations
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA
Institute for Soldier Nanotechnologies, Cambridge, MA 02139, USA
Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA 98105, USA
Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA 98105, USA
Funding
Burroughs Wellcome Fund · National Institutes of Health